Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,565 | -13,771 | -7,589 | -4,554 | -2,011 |
| Depreciation Amortization | 11 | 4,083 | 34 | 23 | 11 |
| Income taxes - deferred | N/A | -193 | N/A | N/A | N/A |
| Accounts receivable | N/A | N/A | N/A | N/A | -60 |
| Accounts payable and accrued liabilities | 142 | -311 | -10 | -142 | 23 |
| Other Working Capital | 225 | -1,036 | -258 | -747 | -256 |
| Other Operating Activity | 355 | 551 | 66 | -66 | -277 |
| Operating Cash Flow | $-2,832 | $-10,675 | $-7,756 | $-5,486 | $-2,570 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 6 | -64 | -64 | -64 | -58 |
| Net Acquisitions | N/A | -93 | N/A | N/A | N/A |
| Investing Cash Flow | $6 | $-157 | $-64 | $-64 | $-58 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -212 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 17,795 | 17,795 | 50 | 8,039 |
| Other Financing Activity | 0 | 0 | 0 | 7,989 | 0 |
| Financing Cash Flow | $N/A | $17,583 | $17,795 | $8,039 | $8,039 |
| Exchange Rate Effect | 39 | -82 | -54 | -12 | 14 |
| Beginning Cash Position | 7,900 | 1,231 | 1,231 | 1,231 | 1,231 |
| End Cash Position | 5,112 | 7,900 | 11,152 | 3,708 | 6,656 |
| Net Cash Flow | $-2,787 | $6,669 | $9,921 | $2,478 | $5,425 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,832 | -10,675 | -7,756 | -5,486 | -2,570 |
| Capital Expenditure | N/A | -64 | -64 | -64 | -58 |
| Free Cash Flow | -2,832 | -10,739 | -7,820 | -5,550 | -2,628 |